Search Results:
CLINICAL TRIAL 19603
Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination with Pembrolizumab for First-Line Treatment of Patients with Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19646
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20030
A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node or T3N0 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20159
A Phase 1 Study of ZW49 in Patients with Locally Advanced (Unresectable) or Metastatic HER2-Expressing Cancers
Disease Site: Esophagus, Breast
View Trial DetailsCLINICAL TRIAL 20487
Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease
Disease Site: Brain and Nervous System, Breast, Leptomeningeal (LMD)
View Trial DetailsCLINICAL TRIAL 20631
Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20897
Phase 1 Dose-Escalation, Dose-Expansion Trial of Intratumoral HER2- and HER3-Primed Dendritic Cells Injections for the Treatment of Early-Stage TNBC and ER Low Positive Breast Cancer (DecipHER)
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20899
Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Disease Site: Brain and Nervous System, Breast
View Trial DetailsCLINICAL TRIAL 21378
Phase 1 Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab / Trastuzumab in Patients with Metastatic HER2-Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21587
A Dose-escalation Study of the Safety and Pharmacology of DAN 222 in Subjects with Metastatic Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21609
A Phase I Dose Escalation And Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, And Anti-Tumor Activity Of PF-07260437 In Advanced Or Metastatic Solid Tumors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21673
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety ofHER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy(FLAMINGO-01)
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21757
Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21937
A Prospective, Multi-Center, Randomized, Double-Arm Trial to Determine the Impact of the SELENE System on Positive Margin Rates in Breast Conservation Surgery
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20479
Efficacy of SOAR (Survivors Overcoming and Achieving Resiliency) Survivorship Workshop for Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 22152
Comparative effectiveness of Juntos Después del Cáncer (JDC) among Breast Cancer Survivors and their Intimate Partners
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 16933
Older Breast Cancer Patients: Risk For Cognitive Decline
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20335
Physician Initiated Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21448
Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer
Disease Site: Breast, Brain metastasis
View Trial DetailsCLINICAL TRIAL 21610
The Influence of Psychosocial Factors on Opioid Decision-Making among Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21760
Nutrition and Lifestyle Needs and Behaviors After Breast Cancer Diagnosis
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 22157
A Mixed-Methods Study to Inform the Use of Patient Education and Digital Technology to Increase the Racial/Ethnic Diversity of Clinical Trial Participants
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19000
Evaluation of Anti-Her2 and Anti-Her3 T-Helper Response in Primary Breast Cancer
Disease Site: Breast - Female
View Trial DetailsCLINICAL TRIAL 21452
Evaluating Gut Microbiome As A Biomarker Of Pathological Complete Response In Patients With Early Triple Negative Breast Cancer - A Pilot Study (TCC)
Disease Site: Breast
View Trial Details